| Author |
Message |
Topic: SF1019 |
Nemotoday
Replies: 31
Views: 10676
|
Forum: Aimspro Posted: Wed Aug 13, 2008 10:16 am Subject: Malaysia SF 1019 receives full regulatory approval |
I was sent this today and although it refers to Diabetes etc and not specifically MS, the bit about inflammation is interesting
NOTE: The marketing name change to R-1818 for Malaysia
+++++++++
... |
Topic: show broadcast about MS |
Nemotoday
Replies: 6
Views: 401
|
Forum: General Discussion Posted: Thu Jul 24, 2008 4:20 am Subject: show broadcast about MS |
They do not seem to have released the article yet, but here are some links to the BBC website and their programmes on MS
BBC journalist Elizabeth Quigley gives an insight into her life with Multipl ... |
Topic: Sativex in Europe |
Nemotoday
Replies: 1
Views: 562
|
Forum: Drug Pipeline Posted: Wed Jul 02, 2008 6:33 am Subject: Sativex - Maker of cannabis-based medicines hit by disappoin |
http://www.guardian.co.uk/business/2008/apr/08/pharmaceuticals.healthcare
Maker of cannabis-based medicines hit by disappointing trial
* Katie Allen
* guardian.co.uk,
* Tuesday A ... |
Topic: Combining beta interferon and atorvastatin may increase dise |
Nemotoday
Replies: 0
Views: 259
|
Forum: Regimens Posted: Tue Jun 17, 2008 11:08 am Subject: Combining beta interferon and atorvastatin may increase dise |
| <shortened url |
Topic: My wife is an Aimspro patient |
Nemotoday
Replies: 4
Views: 1649
|
Forum: Aimspro Posted: Mon Jun 16, 2008 10:16 am Subject: Wonder drug lets Billy weigh anchor |
http://www.portsmouth.co.uk/people/Wonder-drug-lets-Billy-weigh.4186622.jp
Wonder drug lets Billy weigh anchor
Published Date:
16 June 2008
By Matt Jackson
Defence correspondent
AT THE ... |
Topic: Enkorten |
Nemotoday
Replies: 24
Views: 3631
|
Forum: Drug Pipeline Posted: Sat Apr 19, 2008 7:25 am Subject: Website for Farmacija - Enkorten |
Found this which is in English
http://www.farmacija.co.ba/ridfar.htm
FAR404
Farmacija developed FAR404 as a novel compound with an immunomodulatory activity and enables cytoprotective effect ... |
Topic: Rituxan Joins List That Fail for Severe Form of MS |
Nemotoday
Replies: 0
Views: 404
|
Forum: Drug Pipeline Posted: Tue Apr 15, 2008 4:29 pm Subject: Rituxan Joins List That Fail for Severe Form of MS |
Wall Street Journal April 15th 2008
http://online.wsj.com/article_email/SB120821848424614629-lMyQjAxMDI4MDE4NTIxMTU4Wj.html
Rituxan Joins List of Treatments That Fail for Severe Form of MS
By ... |
Topic: Innate immune system research |
Nemotoday
Replies: 1
Views: 310
|
Forum: General Discussion Posted: Thu Mar 27, 2008 6:40 am Subject: Innate immune system research |
A very interesting article, which reminded me that I had read something recently about the innate immune system and SF1019 which is a totally unapproved research product.
The Immunosyn website whic ... |
Topic: 17/03/08 - St George's Hospital Trial Judgement |
Nemotoday
Replies: 0
Views: 851
|
Forum: Aimspro Posted: Tue Mar 18, 2008 2:00 am Subject: 17/03/08 - St George's Hospital Trial Judgement |
http://www.davalinternational.com/index_files/news/news_article.php?nid=36
17/03/08 - St George's Hospital Trial Judgement
The Board of Daval International Limited decided, in 2004, to termina ... |
Topic: Aimspro gets Approval for Phase IIB Trial |
Nemotoday
Replies: 4
Views: 1372
|
Forum: Aimspro Posted: Sat Jan 26, 2008 8:42 am Subject: How Aimspro works. (Mechanism of action?) |
http://www.proventus.org.uk/page81.html
From the Proventus website.
How Aimspro works.
"Aimspro has been characterised biochemically and its mode of action has been determined.
it is compo ... |
Topic: Aimspro gets Approval for Phase IIB Trial |
Nemotoday
Replies: 4
Views: 1372
|
Forum: Aimspro Posted: Sat Jan 26, 2008 8:35 am Subject: Aimspro Bladder Trial - Recruits needed |
Posted on the Proventus website
http://www.proventus.org.uk/
Aimspro Bladder Trial - Recruits needed
The trial for secondary progressive multiple sclerosis bladder function problems is to be ... |
Topic: Rituxan results from ECTRIMS |
Nemotoday
Replies: 32
Views: 5093
|
Forum: Drug Pipeline Posted: Sat Dec 08, 2007 3:56 pm Subject: An interesting piece |
http://www.businessweek.com/magazine/content/07_51/b4063000924207.htm
It is still early days for Rituxan in autoimmune disease, but there have been some important milestones. On a Saturday in the s ... |
Topic: Aimspro gets Approval for Phase IIB Trial |
Nemotoday
Replies: 4
Views: 1372
|
Forum: Aimspro Posted: Mon Nov 26, 2007 9:02 am Subject: Aimspro gets Approval for Phase IIB Trial |
<shortened url>
Daval International Limited Gains Approval for Phase IIB Trial of AIMSPRO(R)
LONDON, November 26 /PRNewswire/ -- Daval International Limited, a UK private company, announce ... |
Topic: SF1019 |
Nemotoday
Replies: 31
Views: 10676
|
Forum: Aimspro Posted: Thu Nov 22, 2007 7:04 am Subject: SF1019 |
Hi Pete,
Can you post the FDA response to you? |
Topic: Article on research by Michael J Fox |
Nemotoday
Replies: 4
Views: 650
|
Forum: General Discussion Posted: Sun Nov 04, 2007 3:10 pm Subject: Article on research by Michael J Fox |
| Well said Harry |
| |